Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral High-Dose Atorvastatin in Relapsing-Remitting Multiple Sclerosis
NCT00616187Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Oct 2003
- Primary completion
- Jun 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of atorvastatin in relapsing-remitting multiple sclerosis (RRMS), sponsored by Charité – Universitätsmedizin Berlin. Started Oct 2003; status: completed.
02
Drugs
atorvastatin
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT00616187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00616187.